Daltonics). The molecular ions were measured automatically in linear positive ion mode with the instrument parameters optimized for a range of 2,000-20,000 m/z. The software packages flexControl 3.0 (Bruker Daltonics) and flexAnalysis 3.0 (Bruker Daltonics) were used for mass spectra recording and processing. Spectra identification and analysis were carried out using the MALDI Biotyper 3.0 (Bruker Daltonics). The identification was performed by comparing the obtained spectra with the MALDI Biotyper 3.0 library (version 3.2.1.1). Antimicrobial activity. Bacterial collection of clinical isolates was kindly provided by Lytech Co. Ltd. The MICs for bacteria were determined by a serial two-fold dilution (0.1-256 µg/ml) in Mueller-Hinton Broth (BD) or Anaerobe Basal Broth (Oxoid) in anaerobic conditions for Bacteroides. MIC was defined as the lowest concentration of amicoumacins that prevented the growth of the test organism in 96-well plate after 10-hour cultivation. Prolonged cultivation is undesirable due to spontaneous Ami self-hydrolysis reaction ( Figure 2D ) and leads to overestimated MICs. Bacterial growth time course was monitored using absorbance at 600 nm measured using Varioskan Flash multimode reader (Thermo Fisher Scientific). NGS sequencing. The selected MDE droplets were freeze dried and total DNA was isolated using the QIAamp DNA Investigator Kit (Qiagen). Whole-genome amplification was performed using the REPLI-g Single Cell Kit (Qiagen). Fragment libraries were prepared using the NEBNext® DNA Library Prep Reagent Set for Illumina and the NEBNext® Multiplex Oligos for Illumina® (96 Index Primers) (Illumina) according to the manufacturer's instructions. Sequencing of libraries was performed using the genetic analyzer HiSeq2500, the HiSeq® PE Cluster Kit v4 -cBot™ and the HiSeq® SBS Kit v4 (250 cycles) (Illumina) according to the manufacturer's instructions. For individual strains, genomic DNA (100 ng for each sample) was disrupted into 400-550 bp fragments by Covaris S220 System (Covaris, Woburn, Massachusetts, USA). Fragment libraries were prepared using the NEBNext® DNA Library Prep Reagent Set for Illumina and the NEBNext® Multiplex Oligos for Illumina® (96 Index Primers) (Illumina) according to the manufacturer's instructions. Sequencing of libraries was performed using the genetic analyzer HiSeq2500, the HiSeq® PE Cluster Kit v4 -cBot™, and the HiSeq® SBS Kit v4 (250 cycles) (Illumina) according to the manufacturer's instructions. Bioinformatics. Genome assemblies were performed using SPAdes 3.9.0 (1). Genomes were annotated with prokka (2) . Bacteria abundance in metagenome samples was assessed with Metaphlan2 (3). Comparative analysis of Ami gene clusters (Fig. 2А) were obtained using EMBOSS Stretcher and resulting protein identity was color-coded. Package genoplotR was used to draw the plot. To detect the presence of the clusters similar to Ami cluster in various genomes, genome annotations of all genomes available from NCBI Refseq database were downloaded in a genebank format and amino acid sequences were blasted to proteins of Ami cluster of B. pumilus 124 as reference. Blastp search with 1e-5 e-value threshold was performed. Then we searched for clusters of proteins with blast hits. We demanded that proteins with hits in these clusters were separated from each other no longer than 10 kbp. A chain of such genes with the maximum number of genes in it was further considered. To calculate synteny length, we summed length of all fragments of reference sequence covered by blast HSPs (High Scoring Pairs) to a detected cluster in query genome. To calculate the total blast score we summed scores of best hits for each query sequence. R script to perform these operations is available at github (https://github.com/paraslonic/ami). To build phylogenetic tree, we inferred 16S gene with barrnap (https://github.com/tseemann/barrnap), aligned sequences with MUSCLE v3.8.31 (4) and a Maximum Likelihood tree was built using the PhyML 3.1 tool (5). We performed all reciprocal blastp alignments of protein sequences to obtain maximum likelihood tree for comparison of different biosynthetic clusters plotted in. Blast scores of all hits were summed and normalized by dividing it on the scores of self-hits:
, where i and j are different biosynthetic clusters. Then the maximum likelihood tree was built using 1 − as an input to bionj function from R ape library. Tree then was rooted by the midpoint.
Comparative analysis of gene clusters homologous to Ami cluster ( Fig. 3) were obtained using MultiGeneBlast (6) . To obtain phylogenetic trees of different B. pumilis strains, we inferred onecopy orthologs with Orthofinder 2.2.1 (7), and aligned their nucleotide sequences with MUSCLE v3.8.31. Aligned sequences were concatenated by strain, and a Maximum Likelihood tree was built using the PhyML 3.1 tool. Ami genes in different strains were considered as present if they belonged to the same homology group (inferred with Orthofinder) as genes in B. pumilus 124 strain. Taxonomy tree of the bacteria encoding gens homologous to amiN was built using blastp hits of B. pumilus 124 amiN on nt database ordered by e-value using 1e-65 as a cutoff. Multiple cases of organisms with unidentified taxonomy were merged into one record for every e-value range.
Cultivation of B. pumilus 124 and Ami purification. B. pumilus 124 was cultivated using LB agar (BD) plates and 2YT broth (BD) supplemented with 100 mM NH3 and 50 mM potassium phosphate buffer pH 7.5 at 30℃. For metabolomic studies, B. pumilus 124 was cultivated in different conditions with «activated» (F) and «inactivated» (N) Ami production. The induction of Ami production (F) was performed by cultivation for 24 hours using 25 cm 2 culture flasks without agitation in 5 ml volume. The cultivation conditions with reduced Ami production (N) were achieved by cultivation in 10 ml volume using 50 ml centrifuge tubes with 250 rpm shaking. B. pumilus 124 was cultivated for 24 hours using 750 ml flasks in 50 ml volume with 220 rpm shaking for a high-scale Ami production. The cells were centrifuged at 10,000 g for 10 min. Ami was extracted from supernatant with ethylacetate and dried by rotary evaporation. The extract was dissolved in DMSO and fractionated on RP-HPLC Zorbax C8 (Agilent) column using buffer A (20 mM NH4OAc pH 5.0, 5% ACN), buffer B (20 mM NH4OAc pH 5.0, 80% ACN); flow rate 5 ml/min; gradient rate 0-10 min (0% B), 10-12 min (0-40% B), 12-16 min (40-52% B), 16-17.5 min (52-67% B), 17.5-19 min (67-100% B). Finally, Ami was purified on Symmetry C18 (Waters) RP-HPLC column using buffer A and B; flow rate 1 ml/min; gradient rate 0-3 min (0% B), 3-4 min (0-30% B), 4-11 min (30-37% B), 11-12 min (37-100% B). Amicoumacin and its derivatives were monitored by absorbance, ε 315 nm MeOH = 4380 M -1 cm -1 for Ami (8) . Metabolomic analysis of Ami and its derivatives. Culture medium was collected after 24 hours of cultivation and frozen in liquid nitrogen. Cells count in F and N samples were normalized using absorbance at 600 nm. Cells were washed with 50 mM Tris-HCl pH 7.2 and lysed by vortexing with acid-washed glass beads (Sigma-Aldrich) on ice. Cell lysates were filtered using 3 kDa Amicon Ultra Centrifugal Filters (Millipore) and frozen in liquid nitrogen. Samples were analyzed with an LC-MS/MS system consisting of a nanopump (G2226A) with a four-channel microvacuum degasser (G1379B), a microfluidic chip cube (G4240-64000) interfaced to a Q-TOF mass spectrometer (6530), a capillary pump (G1376A) with degasser (G1379B), and an autosampler with thermostat (G1377A) (all Agilent technologies). All modules were controlled by Mass Hunter software (version B.06.00, Agilent technologies). A microfluidic reversed-phase HPLC chip (Zorbax 300SB-C18, 5-μm particle size, 75-μm i.d., and 150-mm length) was used to separate the samples. A mixture of 96.9% water, 3% acetonitrile, and 0.1% formic acid (v/v) was used as the sample loading buffer and buffer A. Buffer B was 90% ACN, 9.9% water, and 0.1% formic acid (v/v). The samples were loaded on a trap-column at a flow rate of 3 µl/min for 5 min and eluted with a linear 20-min gradient of 0-80% buffer B at a flow rate of 300 nl/min. After each gradient, the column was washed with 100% buffer B for 5 min and reequilibrated with buffer A for 5 min. Raw MS/MS data were analyzed by Agilent MassHunter workstation software (B.06.00) with Qualitative Analysis (6.0.633.0) software. Acceptance criteria included a match to retention time (within 0.015 minutes), isotope spacing and abundance, accurate mass (within 5 ppm), and fragmentation spectra. Ami phosphorylation by AmiN and dephosphorylation by AmiO. AmiN and amiO genes were amplified from B. pumilus DNA by PCR and cloned into DHFR Control Template plasmid (NEB) using NdeI/KpnI restriction sites. Recombinant AmiN, AmiO and the respective 6xHis-tagged proteins were produced in E.coli BL21(DE3) using autoiduction protocol (9) . Recombinant proteins were purified using metal affinity chromatography on cOmplete™ His-Tag column (Roche), anion exchange chromatography on Mono Q (GE), and size exclusion chromatography on Superdex 75 GL (GE). In vitro phosphorylation was performed in AmiN reaction buffer (50 mM Tris-HCl pH 8.0, 10 mM Mg(OAc)2, 0.1 mM EDTA, 1 mM ATP) using 1.4 nM AmiN and 60 µM Ami. In vitro dephosphorylation was conducted in AmiO reaction buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM MgCl2, 0.2 mM CoCl2, 0.2 mM ZnCl2) using 5 nM AmiO and 40 µM AmiA-P. Reaction mix was analyzed using Symmetry C18 (Waters) RP-HPLC column (1 mL/min, linear gradient 5-80% ACN with 20 mM NH4OAc pH 5.0, in 20 min). Reaction products were subsequently analyzed by LC-MS/MS spectrometry. Reconstitution of AmiN and AmiO activity in B. subtilis 168. B. subtilis 168 yerI gene encodes putative phosphotransferase, which is highly homologous to B. pumilus AmiN kinase. Construction of B. subtilis 168 ΔyerI strain was performed as described in (10) . Briefly, a fragment of the yerI gene generated by PCR using yerI_F (5'-TTATATGGATCCTATATGATGGGAGAGATGGAATG-3') and yerI_R (5'-TTATATCTCGAGCGTAGTTGTCCTGGCTTTTC-3') primers was inserted into temperaturesensitive pSC vector between BamHI and XhoI sites. Electrocompetent B. subtilis 168 cells were transformed with pSC-yerI vector and cells carrying insertion at yerI gene were selected at 37°C on LB agar supplemented with 5 µg/ml erythromycin. Curing of the integrated vector was carried out using pCRE-PAS plasmid. B. pumilis amiN and amiO genes were amplified with amiN_F (5'-TTATATGGATCCCAGCATGCATAAAGATGTAAAAGC-3') and amiN_R (5'-TTATATGACGTCTTAAGATTGACTTAGCTTTGTAAAGTCA-3'), and amiO_F (5'-TTATATGGATCCCAGCATGGGCTATATGGATCGTAAAAAAC-3') and amiO_R (5'-TTATATGACGTCTTATGGGCGATAGGTGGACG-3') primer pairs, respectively. Obtained PCR products were inserted into the pHT-01 vector (MoBiTech GmbH) between BamHI and AatII. For the phenotypic assay, the B. subtilis 168 ΔyerI cells were transformed with either the pHT-amiN, pHT-amiO or control pHT01 plasmid, and expression of the genes was induced with 1mM IPTG. MS sample preparation and measurements. Dry pellets prior to mass spectrometry analysis were resuspended in 500 μl of 20% acetonitrile in water (v/v). After brief rigorous vortexing the samples were shaken for 10 min at 4℃, sonicated in an ice-cooled sonication bath for 10 min, and centrifuged 10 min at 14.000 g at 4℃. Then 900 μl of mixture of 20% acetonitrile in water with 0.1% formic acid (v/v) solution was added to 100 μl of supernatant. After brief rigorous vortexing, 100 μl of diluted sample were transferred to Hamilton glass syringe (100 μl, Hamilton Company, Romania) and placed into the KD Scientific Syringe Pumps (USA). The flow rate was set to 500 nl/min. The mass spectra ( Supplementary Fig. 13-18 ) were acquired in direct injection and positive ionization mode using TripleTOF 5600+ mass spectrometer with a NanoSpray III ion source (AB Sciex, Framingham, MA). We applied the following source parameters: the nanospray needle voltage was set to 3,500 V, curtain gas was set to 50, ion source gas 1 was set to 20, spray temperature was 150℃. MS1 and MS2 spectra were obtained with the following parameters: mass range 50-2000 m/z, number of cycles 100, period cycle time 1000 ms, and accumulation time 1000 ms. Collision-activated dissociation was performed with nitrogen gas with the collision energy ramped from 10 to 70 V with step 1 V per 1 sec. Sample preparation for proteomics. Reduction, alkylation, and digestion of the proteins were performed as described previously (11) . Briefly, sodium deoxycholate (SDC) reduction and alkylation buffer pH 8.5 were added to a sample contained 100 µg protein so that the final concentrations of protein, TRIS, SDC, TCEP, and 2-chloroacetamide were 1 mg/ml, 100 mM, 1% (w/v), 10 mM and 40 mM, respectively. The solution was boiled for 10 min and the equal volume of trypsin solution in 100 mM TRIS pH 8.5 was added in a 1:100 (w/w) ratio. After overnight digestion at 37℃, peptides were acidified by 1% trifluoroacetic acid (TFA) for SDB-RPS binding, and 20 µg was loaded on two 14-gauge StageTip plugs. Ethylacetate/1% TFA (125 µl) was added, and the StageTips were centrifuged at 300 g. After washing the StageTips, peptides were eluted by 60 µl 80% acetonitrile/5% ammonia mixture. The collected material was stored at -80℃. The peptides were suspended in 2% acetonitrile/0.1% TFA buffer and sonicated for 2 min before the analyses. Liquid chromatography and mass spectrometry of proteome samples. Approximately 1 µg of peptides were loaded for 2 h gradient. Peptides were separated on a 25-cm 75-µm i.d. column packed in-house with Aeris Peptide XB-C18 2.6 µm resin (Phenomenex). Reverse-phase chromatography was performed with an Ultimate 3000 Nano LC System (Thermo Fisher Scientific), which was coupled to the Q Exactive HF benchtop Orbitrap mass spectrometer (Thermo Fisher Scientific) via a nanoelectrospray source (Thermo Fisher Scientific). Peptides were loaded in buffer A (0.2% (v/v) formic acid) and eluted with a linear 120-min gradient of 4-45% buffer B (0.1% (v/v) formic acid, 80% (v/v) acetonitrile) at a flow rate of 350 nl/min. The column was washed with 95% buffer B for 5 min and reequilibrated with buffer A for 5 min after each gradient. Column temperature was maintained at 40°C. Peptides were analyzed on a mass spectrometer, with one full scan (300-1,400 m/z, R = 60,000 at 200 m/z) at a target of 3e6 ions and max ion fill time 60 ms, followed by up to 15 data-dependent MS/MS scans with higherenergy collisional dissociation (HCD) (target 1e5 ions, max ion fill time 30 ms, isolation window 1.2 m/z, normalized collision energy (NCE) 28%, underfill ratio 2%), detected in the Orbitrap (R = 15,000 at fixed first mass 100 m/z). Other settings: charge exclusion -unassigned, 1, >6; peptide match -preferred; exclude isotopes -on; dynamic exclusion -30 s was enabled. Proteomic data analysis. Label-free protein was quantified by MaxQuant software version 1.5.6.5 and a common contaminants database by the Andromeda search engine (12) , with cysteine carbamidomethylation as a fixed modification and N-terminal acetylation and methionine oxidations as variable modifications. Peak lists were searched against the database of CDS sequences which was obtained after genome annotation with prokka (2). The FDR was set to 0.01 for both proteins and peptides with a minimum length of seven amino acids. Peptide identification was performed with an allowed initial precursor mass deviation up to 20 ppm and an allowed fragment mass deviation of 20 ppm. The downstream bioinformatics analysis was carried out with Perseus (13) (versions 1.5.5.1). Protein groups only identified by site, only from peptides identified also in the reverse database, or belonging to the common contaminants database, were excluded from the analyses. For Student's t-test, missing values were imputed with a width of 0.3 and a downshift of 1.8 over the total matrix. Two sample tests were performed in Perseus with s0 set to 0. Label free quantification was performed with a minimum ratio count of 1 (14) . To quantify proteins in each sample, we used the iBAQ algorithm, implemented into MaxQuant software (15) . The normalization of each protein's iBAQ value to the sum of all iBAQ values generates a relative iBAQ (riBAQ) value corresponding to the mole fraction of each protein (16) . **** represents how F differs from N, p<0.0001. The data represent mean ± SD. ND indicates that the peak area is less than 10 4 AU. AmiA (Ami) denotes amicoumacin A, AmiB -amicoumacin B, AmiA-P and AmiB-Pphosphorylated AmiA and AmiB, respectively. 
